News & Events

Philogen to attend 12th Annual World ADC 2022 on March 29-31

Mar 15, 2022

Philogen announces its attendance at the 12th Annual World ADC London 2022.

Samuele Cazzamalli, Head of Small Molecule Therapeutics at Philogen, is giving a lecture entitled “Pan-tumoral Small Molecule-Drug Conjugates targeting Fibroblast Activation Protein in solid lesions”.

Dario Neri, co-founder, CEO and CSO, is giving a lecture entitled “Modulating the Therapeutic Activity of ADCs & SMDCs With Engineered Cytokine Products”.

Please follow the link below for more information

World ADC London 2022